BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37906323)

  • 1. Qualitative assessment of the suitability of the Dysphagia Symptom Questionnaire to monitor dysphagia in children aged 7-10 years with eosinophilic esophagitis.
    Pokrzywinski RM; Goodwin B; Dellon ES; Kodroff E; Brooks A; Bailey A; Williams J; Desai NK
    J Patient Rep Outcomes; 2023 Oct; 7(1):110. PubMed ID: 37906323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis.
    Dellon ES; Irani AM; Hill MR; Hirano I
    Aliment Pharmacol Ther; 2013 Sep; 38(6):634-42. PubMed ID: 23837796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension.
    Hudgens S; Evans C; Phillips E; Hill M
    J Patient Rep Outcomes; 2017; 1(1):3. PubMed ID: 29757322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in Dysphagia and Pain With Swallowing in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension.
    Dellon ES; Collins MH; Katzka DA; Hudgens S; Lan L; Williams J; Vera-Llonch M; Hirano I
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):699-706.e4. PubMed ID: 32272243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.
    Martin LJ; Franciosi JP; Collins MH; Abonia JP; Lee JJ; Hommel KA; Varni JW; Grotjan JT; Eby M; He H; Marsolo K; Putnam PE; Garza JM; Kaul A; Wen T; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jun; 135(6):1519-28.e8. PubMed ID: 26051952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires*.
    Flood EM; Beusterien KM; Amonkar MM; Jurgensen CH; Dewit OE; Kahl LP; Matza LS
    Curr Med Res Opin; 2008 Dec; 24(12):3369-81. PubMed ID: 19032119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis.
    Taft TH; Carlson DA; Simons M; Zavala S; Hirano I; Gonsalves N; Pandolfino JE
    Gastroenterology; 2021 Oct; 161(4):1133-1144. PubMed ID: 34153298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children.
    Kamat S; Yaworsky A; Guillemin I; Krohe M; Litcher-Kelly L; McLafferty M; Lamoureux RE; Lowe C; Chehade M; Spergel JM; Weinfurt K; Turner-Bowker DM
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1856-1863.e3. PubMed ID: 35398552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
    Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
    Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and features of eosinophilic esophagitis in dysphagia: a prospective observational study.
    Murray IA; Joyce S; Palmer J; Lau M; Schultz M
    Scand J Gastroenterol; 2016 Mar; 51(3):257-62. PubMed ID: 26446708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.
    Hirano I; Collins MH; Katzka DA; Mukkada VA; Falk GW; Morey R; Desai NK; Lan L; Williams J; Dellon ES;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):525-534.e10. PubMed ID: 33887475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dysphagia stress test for rapid assessment of swallowing difficulties in esophageal conditions.
    Taft TH; Kern E; Starkey K; Craft J; Craven M; Doerfler B; Keefer L; Kahrilas P; Pandolfino J
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13512. PubMed ID: 30474165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review: Disease Activity Indices in Eosinophilic Esophagitis.
    Warners MJ; Hindryckx P; Levesque BG; Parker CE; Shackelton LM; Khanna R; Sandborn WJ; D'Haens GR; Feagan BG; Bredenoord AJ; Jairath V
    Am J Gastroenterol; 2017 Nov; 112(11):1658-1669. PubMed ID: 29039850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic esophagitis in patients with esophageal atresia and chronic dysphagia.
    Kassabian S; Baez-Socorro V; Sferra T; Garcia R
    World J Gastroenterol; 2014 Dec; 20(47):18038-43. PubMed ID: 25548504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Eosinophilic Esophagitis and Esophageal Food Impaction in the Pediatric Population.
    Ettyreddy AR; Sink JR; Georg MW; Kitsko DJ; Simons JP
    Otolaryngol Head Neck Surg; 2018 Oct; 159(4):750-754. PubMed ID: 29807494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis.
    Mukkada VA; Gupta SK; Gold BD; Dellon ES; Collins MH; Katzka DA; Falk GW; Williams J; Zhang W; Boules M; Hirano I; Desai NK
    J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):760-768. PubMed ID: 37718471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood.
    Menard-Katcher P; Marks KL; Liacouras CA; Spergel JM; Yang YX; Falk GW
    Aliment Pharmacol Ther; 2013 Jan; 37(1):114-21. PubMed ID: 23121227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.
    Kidambi T; Toto E; Ho N; Taft T; Hirano I
    World J Gastroenterol; 2012 Aug; 18(32):4335-41. PubMed ID: 22969196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most children with eosinophilic esophagitis have a favorable outcome as young adults.
    Bohm M; Jacobs JW; Gupta A; Gupta S; Wo JM
    Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 26822685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.